IceCure Medical (ICCM) Net Equity Issued and Repurchased (2021 - 2026)

IceCure Medical (ICCM) has 4 years of Net Equity Issued and Repurchased data on file, last reported at $3.5 million in Q1 2026.

• On a quarterly basis, Net Equity Issued and Repurchased rose 38.06% year-over-year to $3.5 million in Q1 2026; TTM through Mar 2026 was $15.4 million, a 72.34% increase from a year earlier, with the FY2024 full-year figure at $9.2 million, changed N/A from the prior year.
• Net Equity Issued and Repurchased for Q1 2026 stood at $3.5 million, down from $9.2 million in the prior quarter.
• Over the last five years, Net Equity Issued and Repurchased for ICCM reached as high as $9.2 million in Q3 2025 and fell as low as $85000.0 in Q2 2025.
• Historically, Net Equity Issued and Repurchased has averaged $3.1 million across 3 years, with a median of $2.7 million in 2024.
• On a YoY basis, Net Equity Issued and Repurchased climbed as much as 173.15% in 2025 and fell as far as 95.5% in 2025.
• Year by year, Net Equity Issued and Repurchased stood at $1.1 million in 2024, then soared by 733.33% to $9.2 million in 2025, then tumbled by 61.45% to $3.5 million in 2026.
• Per Business Quant data, the three most recent Net Equity Issued and Repurchased figures were $3.5 million in Q1 2026, $9.2 million in Q3 2025, and $85000.0 in Q2 2025.